Publication
Psychosomatic Medicine
36(2):p 115-120
Abstract
Oxygen consumption, carbon dioxide production, and respiratory rate are significantly decreased during the practice of a new, easily-learned relaxation technique. The elements of the technique are a mental device to prevent distracting thoughts, a passive attitude, decreased muscle tonus, and a quiet environment which is as free of visual and auditory stimuli as possible. Sitting quietly with the eyes either open or closed failed to produce the same changes. These physiologic changes are consistent with an integrated hypothalamic response resulting in hypothesized decreased sympathetic activity. This response has recently been termed the “relaxation response.”
Web and Email Links
Related Listings
Journal
Journal of Research and Development in Education
Evaluated self-esteem and locus of control in a group of high school students prior to, during, and following a single academic year. Using a randomized, crossover experimental design, 26 Ss were exposed to either a health curriculum based on elicitation of the relaxation response (RLR) and then a follow-up period, while 24 were assigned to a control health curriculum and then the RLR. Psychological testing was conducted using the Piers-Harris Children's Self Concept Scale and the Now […]
Journal
Behavior Modification
Sleep latency changes following behavioral interventions for sleep-onset insomnia are only moderate because the majority of insomniacs do not achieve good sleeper status at posttreatment. This study evaluated the efficacy of a multifactor behavioral intervention consisting of stimulus control and relaxation-response training (n = 10) compared to stimulus control alone (n = 10) for sleep-onset insomnia. Only the multifactor subjects' mean posttest sleep latency fell within the good sle […]
Journal
Frontiers in Psychiatry
Background: Obsessive-compulsive disorder (OCD) is often a life-long disorder with high psychosocial impairment. Serotonin reuptake inhibitors (SRIs) are the only FDA approved drugs, and approximately 50% of patients are non-responders when using a criterion of 25% to 35% improvement with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). About 30% are non-responders to combined first-line therapies (SRIs and exposure and response prevention). Previous research (one open, one randomi […]

